Research Topic · Peer-Reviewed

Asymptomatic SARS-Cov-2

An asymptomatic SARS-CoV-2 infection is a confirmed infection with the virus that causes COVID-19 in a person who never develops recognizable symptoms of the disease. This differs from pre-symptomatic infection, in which symptoms have not yet appeared but eventually do. Identifying asymptomatic carriers is important…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 17× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

An asymptomatic SARS-CoV-2 infection is a confirmed infection with the virus that causes COVID-19 in a person who never develops recognizable symptoms of the disease. This differs from pre-symptomatic infection, in which symptoms have not yet appeared but eventually do. Identifying asymptomatic carriers is important because such individuals can still shed virus and contribute to onward transmission while remaining unaware of their infection status, complicating outbreak control and case-finding. Detection generally relies on screening rather than symptom-triggered testing, using molecular assays such as RT-PCR, antigen tests, and serological surveys that estimate the share of a population that was infected without illness. The phenomenon intersects with broader questions in coronavirus research, including viral kinetics and how long infectious virus persists, host immune responses, transmission dynamics, and the design of prevention and public-health measures. The International Journal of Coronaviruses publishes peer-reviewed work spanning these areas of SARS-CoV-2 and COVID-19, including studies of viral kinetics under different treatment regimens, molecular and evolutionary analysis of spike glycoprotein sequences, cytokine profiling and immune response, risk of severe outcomes and death, and the epidemiology, transmission, and prevention of the disease across diverse populations and settings.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373
2022

Analysis of Risk of Death due to COVID-19 in Cameroon

Whegang Youdom SolangeCorresponding author
The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19) .
International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-22-4115
2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Asymptomatic SARS-Cov-2, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.